Stocktoria

NRX Pharmaceuticals, Inc. NRXP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-11-20

NRX Pharmaceuticals, Inc. statistics & valuation

Market cap$156.4M
Net margin-1980.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1980.80% 2018201920202021202220232023202320242025
Gross margin (%)
2018201920202021202220232023202320242025
Operating margin (%)
-1122.80% 2018201920202021202220232023202320242025
Return on equity (%)
1.30% -447.30% -536.60% 2018201920202021202220232023202320242025
Shares outstanding
2.7M 2.8M 43.0M 58.8M 66.4M 80.4M 83.9M 8.4M 14.6M 31.7M 2018201920202021202220232023202320242025
Net debt ($)
-$9.5M -$2.3M $1.2M $4.6M 2018201920202021202220232023202320242025
Share buybacks ($)
2018201920202021202220232023202320242025
Return on assets (%)
0.10% 1.30% -1760.50% -284.30% -154.00% -412.20% -688.20% -220.90% 2018201920202021202220232023202320242025
Free cash flow margin (%)
2018201920202021202220232023202320242025
Debt / equity (×)
1.42× 2018201920202021202220232023202320242025
EPS ($)
-$1.51 -$1.98 -$0.60 2018201920202021202220232023202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2023FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin-1122.8%—————————
Net margin-1980.8%—————————
Return on assets-220.9%-688.2%-412.2%——-154.0%-284.3%-1760.5%1.3%0.1%
Return on equity179.6%108.2%257.0%——-536.6%-447.3%118.3%-8.4%1.3%
Debt / equity——-0.78×-1.62×-4.52×1.42×————
Current ratio0.310.150.360.680.871.662.740.060.110.05

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.